Arcturus Therapeutics Holdings Inc. (ARCT) Social Stream



Arcturus Therapeutics Holdings Inc. (ARCT): $17.82

0.18 (-1.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ARCT to Watchlist
Sign Up

ARCTURUS THERAPEUTICS HOLDINGS INC (ARCT) Price Targets From Analysts

Use the tables below to see what analysts covering ARCTURUS THERAPEUTICS HOLDINGS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 11 $140 $25 $73.3 $32.02 128.92%
2021-11-16 10 $140 $27 $78 $32.02 143.6%
2022-01-03 9 $140 $31 $84.375 $32.02 163.51%
2022-01-24 8 $140 $31 $79.571 $32.02 148.5%
2022-01-26 8 $140 $31 $76.428 $32.02 138.69%
2022-02-28 8 $140 $31 $76.428 $32.02 138.69%
2022-03-01 8 $140 $31 $75.428 $32.02 135.57%
2022-04-20 8 $140 $25 $74.285 $32.02 132%
2022-04-21 8 $140 $25 $62.142 $32.02 94.07%
2022-05-09 8 $140 $25 $58.166 $32.02 81.66%
2022-05-11 8 $140 $17 $52.375 $32.02 63.57%
2022-05-24 9 $140 $8 $47.444 $32.02 48.17%
2022-07-19 8 $140 $8 $42.222 $32.02 31.86%
2022-08-10 10 $140 $8 $47.7 $32.02 48.97%
2022-11-01 9 $140 $8 $44.777 $32.02 39.84%
2022-11-03 9 $140 $8 $46 $32.02 43.66%
2022-11-10 9 $140 $14 $47.666 $32.02 48.86%
2022-11-14 9 $140 $14 $40.666 $32.02 27%
2023-03-29 10 $140 $14 $40.666 $32.02 27%
2023-05-09 8 $140 $14 $40.25 $32.02 25.7%
2023-05-11 9 $140 $14 $44.25 $32.02 38.19%
2023-06-30 9 $140 $14 $44.222 $32.02 38.11%
2023-07-03 9 $140 $14 $45.333 $32.02 41.58%
2023-07-17 9 $140 $14 $46.444 $32.02 45.05%
2023-07-24 10 $140 $14 $48.9 $32.02 52.72%
2023-08-08 9 $140 $14 $51.666 $32.02 61.36%
2023-10-25 8 $140 $18 $56.375 $32.02 76.06%
2023-11-15 7 $140 $18 $57.428 $32.02 79.35%
2023-11-28 7 $140 $18 $58.714 $32.02 83.37%

The Trend in the Analyst Price Target


ARCT's average price target has moved down $19.75 over the prior 27 months.

Over the past 35 weeks, ARCT's average upside potential has been 93.01%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-29 10 140 14 40.666 20.17 101.62%
2023-08-08 8 140 18 56.375 25.73 119.1%
2023-10-17 8 140 18 56.375 22.47 150.89%
2023-10-25 8 140 18 56.714 18.93 199.6%
2023-11-15 7 140 18 57.428 22.52 155.01%

ARCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 6 0 0 1 1 7

The Trend in the Broker Recommendations


ARCT's average broker recommendation rating improved by 0.93 over the prior 21 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ARCT as an investment opportunity.

  • In terms of how ARCTURUS THERAPEUTICS HOLDINGS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3938.22% of that group.
  • In the context of stocks in the small market cap category, ARCTURUS THERAPEUTICS HOLDINGS INC's number of analysts covering the stock is greater than 3785.16% of them.
  • In terms of how ARCTURUS THERAPEUTICS HOLDINGS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 3763.32% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ARCTURUS THERAPEUTICS HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 1600.96% of them.

In the Pharmaceutical Products industry, AVDL, ABUS, and LPCN are the three stocks most similar to ARCTURUS THERAPEUTICS HOLDINGS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ARCT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!